A New Way to “Squeeze” Infrared Light Down to Size

SCIENTIFIC ACHIEVEMENT

Using the Advanced Light Source (ALS), researchers demonstrated a new way to confine, or “squeeze,” infrared light by coupling photons with phonons (lattice vibrations) within a certain type of thin film.

SIGNIFICANCE AND IMPACT

The work heralds a new class of optical materials for controlling infrared light, with potential applications in photonics, sensors, and microelectronic heat management.

A light squeeze

Researchers have demonstrated that thin films of strontium titanate (SrTiO3, or STO) can confine, or “squeeze,” infrared light 10 times more than its bulk form can—a finding that holds promise for next-generation microelectronic and photonic devices. While this unusual behavior had been theoretically predicted for STO membranes, it had not yet been experimentally observed.

The researchers took advantage of advances in the synthesis of freestanding, large-scale crystalline oxide membranes, then used a combination of infrared micro- and nanospectroscopy to observe how infrared light couples to lattice vibrations in the membranes. They found that the coupling produced hybrid vibrational and electromagnetic waves (phonon polaritons) in the material, with different modes characterized by highly compressed wavelengths or greatly enhanced fields inside the sample.

Transferable membranes

Theoretical studies have suggested that ultrathin STO and other perovskite membranes can host highly confined surface phonon polaritons (SPhPs) with good propagation quality. Other compounds may have higher figures of merit, but because they are typically manually exfoliated, their lateral size is constrained to the micrometer range, which limits their potential for large-scale device fabrication.

Read more on ALS website

Image: In this experiment, an atomic force microscope tip focuses broadband synchrotron infrared light onto the surface of a strontium titanate (SrTiO3) membrane, just 100 nm thick. The infrared light excites phonon polaritons—quasiparticles that arise when light strongly interacts with dipole oscillations in the material’s lattice. Spectroscopic analysis of the scattered light enabled researchers to determine the properties of phonon polaritons on the material surface.

Improved treatment for patients with kidney failure

USask researchers have developed a better membrane for dialysis machines that could lead to safer treatment, improved quality of life for patients with kidney failure.

Over two million people worldwide depend on dialysis or a kidney transplant, according to the National Kidney Foundation. In Canada, the number of individuals facing kidney failure has climbed 35 per cent since 2009 and nearly half (46 per cent) of new kidney disease patients are under age 65, according to The Kidney Foundation of Canada.

Using the Canadian Light Source (CLS) at the University of Saskatchewan (USask), researchers have developed a better membrane for dialysis machines that could lead to safer treatment and improved quality of life for patients with kidney failure.

A dialysis machine is used to filter toxins, waste products, salts, and excess fluid from a patient’s blood when their kidneys can no longer perform this function well. However, negative reactions between dialysis membranes and the patient’s blood can lead to serious complications like blood clots, heart conditions, anemia, blood poisoning, infections, and more.

Dr. Amira Abdelrasoul, an associate professor with USask’s College of Engineering, is an expert on membranes and is determined to help patients on dialysis. “I lost a close family member due to dialysis,” she said. “I saw all the complications he experienced and how he suffered. So, I put all my efforts, knowledge, and background into this research area because I would like to support patients and avoid anyone having to lose a loved one from this treatment.”

The new dialysis membrane developed by her team is a significant improvement over those used in hospitals today, according to Abdelrasoul. Some of the commercial membranes currently in use contain heparin, a medicine that reduces blood clots; however, they also have an intense negative charge on their surface that causes serious side effects.

Read more on the CLS website